DaVita
DVA
#1877
Rank
A$16.15 B
Marketcap
A$256.78
Share price
-0.70%
Change (1 day)
42.17%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$20.21

According to DaVita's latest financial reports the company's current EPS (TTM) is A$20.60. In 2025 the company made an earnings per share (EPS) of A$15.02 a decrease over its 2024 EPS that were of A$16.37.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$20.2134.52%
2025A$15.02-8.25%
2024A$16.3744.94%
2023A$11.3027.26%
2022A$8.88-35.56%
2021A$13.7744.1%
2020A$9.5619.7%
2019A$7.99540.48%
2018A$1.25-76.07%
2017A$5.21-19.31%
2016A$6.46242.52%
2015A$1.89-62.87%
2014A$5.0813.43%
2013A$4.488.45%
2012A$4.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$35.86 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$18.21-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$51.52 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.80-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA